Events and Conferences

Contact Veristat Now


Request A Proposal

Contact Us

On-Demand Webinar| Expanding your Clinical Trial into the US - Submit your IND for non-US Sponsors

May 20, 2021

How, why, and when to expand your clinical trial program into the US, including differences between IND and CTA 

Read More

On-Demand Webinar | What's New in Draft MHPD Guidance on Reporting Adverse Reactions for Marketed Products

April 12, 2021

Certus PV, a Veristat Company experts recently lead an Xtalks webinar - View it On-Demand Now

Read More

On-Demand Webinar | How to Better Plan Your Decentralized/Virtual Clinical Trial

March 2, 2021

Veristat experts recently led an Xtalks webinar on lessons learned for planning decentralized clinical trials.

Read More

Gene Therapy for Rare Disorders 2021

January 22, 2021

Meet Veristat at the Virtual event taking place 23-24 February 2021

Read More

Webinar | Roadmap to Market for Cell and Gene Therapies

October 12, 2020

View the On-Demand Webinar

VIEW WEBINAR

Nothing is standard about the study design, study conduct or the regulatory process in cell and gene therapy trials. Every cell and gene therapy is different due to the specific characteristics of each product, with a complicated regulatory approval process and unique therapeutic challenges.

 

Read More

Webinar | Reducing Study Build Time from Weeks to Days

October 1, 2020

View Webinar On-Demand

VIEW ON-DEMAND

Study start-up and post-go-live protocol amendments can be lengthy, costly, and disruptive to a clinical trial. But with the right technology, data managers can accelerate timelines and overcome these challenges.

Read More

Cell and Gene Meeting On The Mesa

August 3, 2020

Meet Veristat at the Virtual event taking place October 12-14, 2020.

Read More

Gene Therapy for Rare Disorders Europe

August 3, 2020

Meet Veristat at the Virtual event taking place 26-28 October 2020.

Read More

Webinar | Minimize Disruption of Your Oncology Trial

June 4, 2020

View the On-Demand Webinar 

VIEW WEBINAR

As the world begins to relax restrictions, what are the lessons learned that can catapult us into the next innovation in trial operations for good? 
Read More

Webinar | Are you Ready to Begin Planning your IND Submission?

April 13, 2020

View the On-Webinar

VIEW WEBINAR

Submitting an Investigational New Drug (IND) application to the US FDA is a significant step in the development of a new drug or biologic product. But, are you ready? 
Read More